After proof-of-concept studies in China, a highly sensitive SARS-CoV-2 detection kit was developed, intended for the qualitative detection of reported conserved viral nucleic acid sequences, Nucleoprotein N (FAM) and ORF1ab (HEX), using Crystal Digital PCR™. This kit is designed to offer an advantage over the conventionally used qPCR by detecting low concentration targets in a large sample volume where qPCR was leading to unreliable result interpretation due to high Ct values. The SARS-CoV-2 multiplex Crystal Digital PCR™ kit has emerged as a powerful tool and a powerful alternative to the traditional qPCR technique. Test results indicate a robust and specific detection of SARS-CoV-2 sequences down to 5 copies per 25µl reaction (equivalent to 0.2 cp/µl) for ORF1ab and for Nucleoprotein N: down to 7 copies per 25µl reaction (equivalent to 0.28 cp/µl)). The kit includes reagents, Sapphire chips, and COVID-19 positive and negative controls.